Nivolumab Interactions
There are 588 drugs known to interact with nivolumab, along with 5 disease interactions. Of the total drug interactions, 3 are major, and 585 are moderate.
- View all 588 medications that may interact with nivolumab
- View nivolumab disease interactions (5)
Most frequently checked interactions
View interaction reports for nivolumab and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Ativan (lorazepam)
- Benadryl (diphenhydramine)
- Breo Ellipta (fluticasone / vilanterol)
- Cabometyx (cabozantinib)
- Calcium 600 D (calcium / vitamin d)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- Fentanyl Transdermal System (fentanyl)
- Januvia (sitagliptin)
- Keppra (levetiracetam)
- Keytruda (pembrolizumab)
- Mekinist (trametinib)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Norco (acetaminophen / hydrocodone)
- Nurtec ODT (rimegepant)
- Paracetamol (acetaminophen)
- Prilosec (omeprazole)
- Prilosec OTC (omeprazole)
- Protonix (pantoprazole)
- Revlimid (lenalidomide)
- Senokot (senna)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xgeva (denosumab)
- Zometa (zoledronic acid)
Nivolumab disease interactions
There are 5 disease interactions with nivolumab which include:
Report options
QR code containing a link to this page
More about nivolumab
- nivolumab consumer information
- Compare alternatives
- Reviews (139)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
